The primary role of the kidney and salt intake in the aetiology of essential hypertension. IIDE WARDENER, H. E.Clinical science (1979). 1990, Vol 79, Num 4, pp 289-297, issn 0143-5221Article

Sodium et hypertension = Sodium and hypertensionDE WARDENER, H.-E.Archives des maladies du coeur et des vaisseaux. 1996, Vol 89, pp 9-15, issn 0003-9683, NS4Conference Paper

Kidney, salt intake, and Na⁺, K⁺-ATPase inhibitors in hypertension : 1990 Corcoran lectureDE WARDENER, H. E.Hypertension (Dallas, Tex. 1979). 1991, Vol 17, Num 6, pp 830-836, issn 0194-911X, 7 p., p.2Conference Paper

Salt reduction and cardiovascular risk: the anatomy of a mythDE WARDENER, H. E.Journal of human hypertension. 1999, Vol 13, Num 1, pp 1-4, issn 0950-9240Article

Sodium and the kidney in essential hypertensionDE WARDENER, H. E.Journal of human hypertension. 1996, Vol 10, Num 10, pp 645-648, issn 0950-9240Conference Paper

The primary role of the kidney and salt intake in the aetiology of essential hypertensio. IDE WARDENER, H. E.Clinical science (1979). 1990, Vol 79, Num 3, pp 193-200, issn 0143-5221Article

The concept of the natriuretic hormone and its relation to hypertensionDE WARDENER, H. E.Clinical and experimental hypertension. Part A, Theory and practice. 1985, Vol 7, Num 5-6, pp 647-662, issn 0730-0077Article

On the assertion that a moderate restriction of sodium intake may have adverse health effectsDE WARDENER, H. E; KAPLAN, N. M.American journal of hypertension. 1993, Vol 6, Num 9, pp 810-814, issn 0895-7061Article

Concept of natriuretic hormoneDE WARDENER, H. E; CLARKSON, E. M.Physiological reviews. 1985, Vol 65, Num 3, pp 658-759, issn 0031-9333Article

Harmful effects of dietary sait in addition to hypertensionDE WARDENER, H. E; MACGREGOR, G. A.Journal of human hypertension. 2002, Vol 16, Num 4, pp 213-223, issn 0950-9240Article

Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urineCLARKSON, E. M; DE WARDENER, H. E.Clinical and experimental hypertension. Part A, Theory and practice. 1985, Vol 7, Num 5-6, pp 673-683, issn 0730-0077Article

Digoxin-like inhibitors of active sodium transport and blood pressure : the current statusWOOLFSON, R. G; POSTON, L; DE WARDENER, H. E et al.Kidney international. 1994, Vol 46, Num 2, pp 297-309, issn 0085-2538Conference Paper

Extraction and characterization of a cytochemically assayable Na⁺/K⁺-ATPase inhibitor/glucose-6-phosphate dehydrogenase stimulator in the hypothalamus and plasma of man and the ratMILLETT, J. A; HOLLAND, S. M; ALAGHBAND-ZADEH, J et al.Journal of endocrinology. 1987, Vol 112, Num 2, pp 299-303, issn 0022-0795Article

Na-K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive ratMILLETT, J. A; HOLLAND, S. M; ALAGHBAND-ZADEH, J et al.Journal of endocrinology. 1986, Vol 108, Num 1, pp 69-73, issn 0022-0795Article

Salt, blood pressure and health: a cautionary tale. Commentaries. Author's replyALDERMAN, Michael H; ELLIOTT, P; STAMLER, J et al.International journal of epidemiology. 2002, Vol 31, Num 2, pp 311-332, issn 0300-5771Article

A possible connection between an increased concentration of a cytochemically detectable substance in the hypothalamus of the spontaneously hypertensive rat and certain cerebral cholinergic disturbancesDE WARDENER, H. E; HOLLAND, S; ALAGHBAND-ZADEH, J et al.Journal of cardiovascular pharmacology. 1993, Vol 22, pp S109-S111, issn 0160-2446, SUP2Conference Paper

Hypothalamic hypertensive factor : An inhibitor of nitric oxide synthase activityMORRIS, H. R; ETIENNE, A. T; DE WARDENER, H. E et al.Hypertension (Dallas, Tex. 1979). 1997, Vol 30, Num 6, pp 1493-1498, issn 0194-911XArticle

Effect of hemicholinium-3 on the hypothalamic concentration of a cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating substanceVARGAS, H. M; BREZENOFF, H. E; MORRIS, H. R et al.Journal of cardiovascular pharmacology. 1994, Vol 24, Num 5, pp 773-778, issn 0160-2446Article